Wednesday, May 25, 2005

Long-term risk of breast cancer recurrence: the need for extended adjuvant therapy

05/25/2005 Kaufmann M, Rody A. J Cancer Res Clin Oncol.
"On the basis of these results, extended adjuvant letrozole is recommended for all patients completing 5 years of adjuvant tamoxifen, including women generally considered at minimal risk."


Post a Comment

<< Home

/* WebRing Code */